Showing results (181-190 of 204) with videos related to

Sort By:
Pageof 21
Journal of Public Health (Oxford, England)|December 16, 2004
What has happened to antimicrobial usage in primary care in the United Kingdom since the SMAC report? - description of trends in antimicrobial usage using the General Practice Research DatabaseGillian E Smith, Sue Smith, Heath Heatlie, et al.
Frontiers in Neurology|August 21, 2024
Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodiesAni C Khodavirdi, Jasjit K Multani, Sam S Oh, et al.
The Journal of Headache and Pain|July 24, 2021
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trialsStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
Frontiers in Neurology|March 13, 2023
Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION-A phase 4, multinational, randomized, double-blind, placebo-controlled studyRigmor H Jensen, Henrik Winther Schytz, Cristina Tassorelli, et al.
JAMA Neurology|May 19, 2025
Efficacy and Safety of Eptinezumab in Episodic Cluster Headache: A Randomized Clinical TrialRigmor H Jensen, Cristina Tassorelli, Stewart J Tepper, et al.
Cephalalgia : an International Journal of Headache|December 3, 2020
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extensionRichard B Lipton, Stewart J Tepper, Stephen D Silberstein, et al.
Drugs in R&D|January 8, 2016
Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical StudiesPaul Martin, Michael Gillen, David Millson, et al.
Headache|January 27, 2023
Remote electrical neuromodulation for migraine prevention: A double-blind, randomized, placebo-controlled clinical trialStewart J Tepper, Liron Rabany, Robert P Cowan, et al.
The Lancet. Neurology|April 19, 2025
Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trialCristina Tassorelli, Rigmor H Jensen, Peter J Goadsby, et al.
Neurology|April 19, 2019
Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trialStewart J Tepper, Hans-Christoph Diener, Messoud Ashina, et al.
Pageof 21